(Q62110897)

English

Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Randomized Multicenter Study to Compare the Safety and Efficacy of 166Ho-DOTMP Plus Melphalan to Melphalan Alone as Conditioning for Autologous Peripheral Blood Stem Cell Transplant in Subjects With Primary Refractory Multiple Myeloma (English)

0 references

0 references

0 references

United States of America

0 references

start time

March 2004

0 references

number of participants

240

0 references

research intervention

melphalan

0 references

clinical trial phase

phase III clinical trial

0 references

research site

University of Alabama

0 references

Rocky Mountain Cancer Centers

0 references

University of Iowa Health Care

0 references

University of Nebraska Medical Center

0 references

Case Western Reserve University

0 references

Vanderbilt University Medical Center

0 references

Virginia Commonwealth University

0 references

Medical College of Wisconsin

0 references

University of Miami

0 references

Fred Hutchinson Cancer Research Center

0 references

research subject recruitment status

terminated

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00083564

0 references

(Q62110897)

Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)